Prognostic markers and DNA methylation profiling in lymphoid malignancies
In recent years, great progress has been achieved towards identifying novel biomarkers in lymphoid malignancies, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), at the genomic, transcriptomic and epigenomic level for accurate risk-stratification and prediction of treatme...
Main Author: | Bhoi, Sujata |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Experimentell och klinisk onkologi
2017
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-328616 http://nbn-resolving.de/urn:isbn:978-91-513-0053-5 |
Similar Items
-
Recurrent Genetic Mutations in Lymphoid Malignancies
by: Young, Emma
Published: (2017) -
Plasma hepatic enzymes as biopredictors of type, metastasis, and prognostication of hematological malignancies
by: Abdulazeez Adelaja Akinlolu, et al.
Published: (2018-01-01) -
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
by: XiaoYan Yue, et al.
Published: (2020-10-01) -
Leucémie lymphoïde chronique : étude des marqueurs du pronostic et de l'instabilité génomique
by: Veronese, Lauren
Published: (2013) -
Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy
by: Johanna Claustre, et al.
Published: (2020-06-01)